DECADRON-LA Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Decadron-la, and when can generic versions of Decadron-la launch?
Decadron-la is a drug marketed by Merck and is included in one NDA.
The generic ingredient in DECADRON-LA is dexamethasone acetate. There are thirty-nine drug master file entries for this compound. Additional details are available on the dexamethasone acetate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DECADRON-LA?
- What are the global sales for DECADRON-LA?
- What is Average Wholesale Price for DECADRON-LA?
Summary for DECADRON-LA
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 69 |
| Clinical Trials: | 517 |
| Patent Applications: | 2,095 |
| DailyMed Link: | DECADRON-LA at DailyMed |
Recent Clinical Trials for DECADRON-LA
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Miami | Phase 3 |
| Orion Corporation, Orion Pharma | Phase 1 |
| Merck Sharp & Dohme LLC | Phase 1 |
US Patents and Regulatory Information for DECADRON-LA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Merck | DECADRON-LA | dexamethasone acetate | INJECTABLE;INJECTION | 016675-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
